Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Jiandao Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates modern production facilities that comply with Good Manufacturing Practice (GMP) standards to ensure high-quality output for domestic and international markets. Its product portfolio primarily includes treatments for chronic conditions such as cardiovascular diseases, metabolic disorders, and infectious diseases. Shandong Jiandao Pharmaceutical emphasizes the integration of R&D with large-scale production to provide cost-effective therapeutic solutions. The company is positioned as a key player in the regional pharmaceutical industry in Shandong province, contributing to the supply chain of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Jiandao Pharmaceutical.